SCHOTT Pharma AG & Co. KGaA (SHTPY)
4.37
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
SCHOTT Pharma Profit Margin (Quarterly) : 13.83% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 13.83% |
| March 31, 2026 | 12.56% |
| December 31, 2025 | 13.86% |
| September 30, 2025 | 13.60% |
| June 30, 2025 | 17.80% |
| March 31, 2025 | 15.21% |
| December 31, 2024 | 12.87% |
| Date | Value |
|---|---|
| September 30, 2024 | 14.42% |
| June 30, 2024 | 18.31% |
| March 31, 2024 | 10.76% |
| December 31, 2023 | 19.17% |
| September 30, 2023 | 15.19% |
| December 31, 2022 | 16.94% |
| September 30, 2022 | 12.63% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| West Pharmaceutical Services, Inc. | 17.65% |
| Drägerwerk AG & Co. KGaA | 3.42% |
| Sartorius AG | 10.17% |
| Reflect Scientific, Inc. | 22.30% |
| Ottobock SE & Co. KGaA | 10.59% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 14.83% |
| Return on Assets | 8.48% |
| Return on Invested Capital | 14.56% |
| Gross Profit Margin (Quarterly) | 30.66% |
| Operating Margin (Quarterly) | 15.88% |
| Return on Net Operating Assets | 10.51% |